I suppose the next quarterly report will be telling in just how good PLS has been at negotiating a better price.
I do note they use a pricing model based of a calculation of the combined carbonate and hydroxide price. This is good as they are definitely steaming ahead moreso than the spodumene spot price.
My view is we need to see some real paper profits before we can judge management one way or the other.
Ann: Yibin Tianyi Offtake and Prepayment, page-57
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.91 |
Change
-0.090(3.00%) |
Mkt cap ! $8.763B | |||
| Open | High | Low | Value | Volume |
| $3.02 | $3.06 | $2.90 | $43.68M | 14.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12200 | $2.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.92 | 3400 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| PLS (ASX) Chart |